This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $2325 | To Be Confirmed |
200mg | $3485 | To Be Confirmed |
500mg | $5885 | To Be Confirmed |
Cat #: V15104 CAS #: 869998-49-2 Purity ≥ 99%
Description: SPD-304 is a novel, potent and selective inhibitor of tumor necrosis factor α (TNFα) with an IC50 of 22 µM for preventing binding to the TNF Receptor 1 (TNFR1).
References: Molly M. He, et al. Small-Molecule Inhibition of TNF-α. Science 11 Nov 2005.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 547.61 |
---|---|
Molecular Formula | C32H32F3N3O2 |
CAS No. | 869998-49-2 |
SMILES Code | O=C1C(CN(C)CCN(C)CC2=CN(C3=CC=CC(C(F)(F)F)=C3)C4=C2C=CC=C4)=COC5=CC(C)=C(C)C=C15 |
Synonyms | SPD-304, SPD 304, SPD304 |
Protocol | In Vitro | SPD304 (2 μM) significantly rescues the survivability of aHSCs, reduces the production of lipid hydroxides, and increased intracellular GSH. The co-treatment of GA (75 μM) and SPD304 (2 μM), down-regulate TRADD almost 2-fold (w/o inhibitor vs. w/ inhibitor) and p−RIP3 1.4−fold compared to GA alone, and promotes caspase 8 activation. |
---|---|---|
In Vivo | SPD304 cannot be used in vivo due to its high toxicity. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.8261 mL | 9.1306 mL | 18.2612 mL | 36.5223 mL |
5mM | 0.3652 mL | 1.8261 mL | 3.6522 mL | 7.3045 mL |
10mM | 0.1826 mL | 0.9131 mL | 1.8261 mL | 3.6522 mL |
20mM | 0.0913 mL | 0.4565 mL | 0.9131 mL | 1.8261 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.